Titan Biotech Limited (BOM:524717)

Titan Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	47.29	18.73	55.58	32.86	48.64	68.14
Cash & Short-Term Investments	47.29	18.73	55.58	32.86	48.64	68.14
Cash Growth	31.40%	-66.30%	69.18%	-32.45%	-28.62%	25.01%
Accounts Receivable	271.56	228.29	188.16	186.58	210.08	163.59
Receivables	271.56	228.29	188.16	186.58	210.08	163.59
Inventory	635.61	557.69	508.21	455.71	361.7	346.8
Prepaid Expenses	-	4.04	3.17	1.87	1.23	-
Other Current Assets	138.13	43.68	39.96	49.18	61.42	59.03
Total Current Assets	1,093	852.43	795.09	726.2	683.06	637.56
Property, Plant & Equipment	675.16	632.52	588.46	544.7	491.04	385.15
Long-Term Investments	637.6	635.95	347.91	285.48	156.69	40.31
Other Intangible Assets	0.74	0.84	1.22	0.95	0.85	1.05
Other Long-Term Assets	49.2	17.12	14.4	12.93	13.52	16.85
Total Assets	2,455	2,139	1,747	1,570	1,345	1,081

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	112.46	85.41	76.55	33.68	55.5	41.6
Accrued Expenses	8.69	56.72	48.07	66.46	55.51	39.37
Short-Term Debt	38.42	33.44	19.18	67.18	67	64.5
Current Portion of Leases	3.42	9.89	8.9	8.83	3.81	2.9
Current Income Taxes Payable	30.66	12.66	-	-	0.29	3.14
Other Current Liabilities	164.68	61.51	24.66	19.56	21.41	17.99
Total Current Liabilities	358.32	259.63	177.36	195.71	203.51	169.49
Long-Term Debt	3.66	3.27	1.84	4.53	2.99	10.81
Long-Term Leases	13.99	14.43	2.35	6.94	11.32	11.09
Pension & Post-Retirement Benefits	27.23	22.79	16.28	14.83	16.15	14.33
Long-Term Deferred Tax Liabilities	23.67	23.26	15.21	13.72	12.07	12.76
Total Liabilities	426.88	323.37	213.04	235.74	246.04	218.47

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	82.64	82.64	82.64	82.64	82.64	82.64
Additional Paid-In Capital	-	86.75	86.75	86.75	86.75	86.75
Retained Earnings	-	1,643	1,361	1,162	928.21	692.17
Comprehensive Income & Other	1,946	3.11	3.99	3.26	1.51	0.89
Total Common Equity	2,028	1,815	1,534	1,335	1,099	862.44
Shareholders' Equity	2,028	1,815	1,534	1,335	1,099	862.44
Total Liabilities & Equity	2,455	2,139	1,747	1,570	1,345	1,081

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	59.49	61.03	32.27	87.48	85.12	89.3
Net Cash (Debt)	-12.2	-42.3	23.31	-54.63	-36.48	-21.16
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.26	-0.82	0.45	-1.06	-0.71	-0.41
Filing Date Shares Outstanding	41.28	51.65	51.65	51.65	51.65	51.65
Total Common Shares Outstanding	41.28	51.65	51.65	51.65	51.65	51.65
Working Capital	734.27	592.8	617.72	530.49	479.55	468.06
Book Value Per Share	49.14	35.15	29.70	25.84	21.28	16.70
Tangible Book Value	2,028	1,815	1,533	1,334	1,098	861.4
Tangible Book Value Per Share	49.13	35.13	29.68	25.82	21.26	16.68
Buildings	-	242.53	218.37	207.56	130.34	130.25
Machinery	-	523.78	474.05	391.37	281.77	254.21
Construction In Progress	-	17.27	16.84	25.32	132.94	36.34

Data Source: S&P Global Market Intelligence Last updated: Nov 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error